COR

Cencora, Inc.
$264.69 -1.73%

Recent alerts on COR

All signals →
Insider trade Purchase by DURCAN DERMOT MARK
4d ago
News Cencora appoints Eva Boratto as CFO, reaffirms guidance
6d ago
News Cencora raises earnings outlook on share repurchases
11d ago
News Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook
14d ago
News Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings
14d ago
News Cencora (COR) Stock Nosedives: Here's What Caused the Decline
14d ago
News Cencora (COR) Gains 13.2% YTD: What's Driving the Stock?
14d ago
News Reasons to Hold Cencora (COR) Stock in Your Portfolio for Now
14d ago
News Most healthcare companies report higher Y/Y EPS in strong earnings week
24d ago
News Cencora declares $0.60 dividend
27d ago
News Cencora gives mixed Q2 numbers, guides FY EPS above consensus
27d ago
SEC filing COR Acquires EyeSouth Retina Business for $1.1B, Reaffirms 2026 Guidance, Slight EPS Accretion
71d ago
SEC filing COR Retires CFO Cleary, Reaffirms FY26 EPS Guidance
77d ago
News Cencora’s animal health unit to merge with Covetrus in $3.5B transaction
104d ago
SEC filing COR Announces $3.5B MWI Animal Health Merger, $1.25B Cash, $800M Preferred, 34.3% Stake
104d ago
Insider trade Sale by Robert P. Mauch
104d ago
SEC filing COR Sells $3.0B Senior Notes, $500M 3.950% 2029 Notes, $500M 4.250%
108d ago
News Cencora Prices $500 Million 3.950% Senior Notes Due 2029, $500 Million 4.250% Senior Notes Due 2030, $500 Million 4.600% Senior Notes Due 2033, $1.0 Billion 4.900% Senior Notes Due 2036 and $500 Million 5.650% Senior Notes Due 2056 – Compa
111d ago
News Cencora prices $3B in senior notes across multiple maturities
111d ago
News Cardinal Health surges following quarterly earnings beats, guidance raise
117d ago
News Cencora outlines 11.5%-13.5% operating income growth for 2026 while integrating OneOncology
117d ago
News Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss
118d ago
News Lower-Than-Expected Service Bookings Impacted Certara (CERT) in Q4
126d ago
News CereVasc Completes Enrollment of ETCHES Study of the eShunt® System for the Treatment of Communicating Hydrocephalus
132d ago
News Novo’s CEO Is Ready to Go ‘Very Big’ in Hunt for Obesity Deals
139d ago

Get push alerts for COR

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS